| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.849 | 0.003 | 0.849 | Cholesterol antagonist | 0.827 0.004 DBMET00546 | ||
| 0.85 | 0.009 | 0.885 | Antiinflammatory | 0.885 0.006 DBMET00546 | DBMET00546 | |
| 0.826 | 0.004 | 0.882 | Platelet antagonist | 0.882 0.004 DBMET00546 | DBMET00546 | |
| 0.772 | 0.015 | 0.838 | Caspase 9 stimulant | 0.838 0.006 DBMET00546 | DBMET00546 | |
| 0.724 | 0.007 | 0.728 | Antithrombotic | 0.728 0.007 DBMET00546 | DBMET00546 | |
| 0.724 | 0.012 | 0.837 | Cyclophilin D inhibitor | 0.837 0.005 DBMET00546 | DBMET00546 | |
| 0.714 | 0.005 | 0.743 | Hypolipemic | 0.743 0.004 DBMET00546 | DBMET00546 | |
| 0.696 | 0.006 | 0.715 | Vasodilator, peripheral | 0.715 0.005 DBMET00546 | DBMET00546 | |
| 0.694 | 0.032 | 0.697 | Apoptosis agonist | 0.697 0.031 DBMET00546 | DBMET00546 | |
| 0.656 | 0.005 | 0.722 | Apoptosis antagonist | 0.722 0.004 DBMET00546 | DBMET00546 | |
| 0.635 | 0.005 | 0.676 | Platelet aggregation inhibitor | 0.676 0.005 DBMET00546 | DBMET00546 | |
| 0.628 | 0.004 | 0.673 | Platelet adhesion inhibitor | 0.673 0.004 DBMET00546 | DBMET00546 | |
| 0.625 | 0.005 | 0.625 | Vasodilator | 0.614 0.005 DBMET00546 | ||
| 0.633 | 0.027 | 0.633 | Transcription factor NF kappa B inhibitor | 0.604 0.031 DBMET00546 | ||
| 0.611 | 0.012 | 0.611 | Spasmolytic | 0.481 0.026 DBMET00546 | ||
| 0.604 | 0.008 | 0.63 | Hypoglycemic | 0.63 0.007 DBMET00546 | DBMET00546 | |
| 0.582 | 0.004 | 0.582 | Mediator release inhibitor | 0.403 0.005 DBMET00546 | ||
| 0.58 | 0.008 | 0.58 | Tumour necrosis factor alpha release inhibitor | 0.507 0.013 DBMET00546 | ||
| 0.575 | 0.012 | 0.671 | Caspase 3 stimulant | 0.671 0.007 DBMET00546 | DBMET00546 | |
| 0.566 | 0.003 | 0.59 | Vanilloid agonist | 0.59 0.003 DBMET00546 | DBMET00546 | |
| 0.566 | 0.012 | 0.566 | Lipoxygenase inhibitor | 0.522 0.016 DBMET00546 | ||
| 0.542 | 0.01 | 0.69 | Angiogenesis stimulant | 0.69 0.005 DBMET00546 | DBMET00546 | |
| 0.546 | 0.017 | 0.546 | Histamine release inhibitor | 0.533 0.019 DBMET00546 | ||
| 0.536 | 0.017 | 0.536 | GABA C receptor rho-3 antagonist | 0.476 0.033 DBMET00546 | ||
| 0.548 | 0.032 | 0.548 | 15-Lipoxygenase inhibitor | 0.461 0.05 DBMET00546 | ||
| 0.505 | 0.004 | 0.505 | Aldehyde dehydrogenase inhibitor | 0.48 0.005 DBMET00546 | ||
| 0.524 | 0.024 | 0.524 | 5 Hydroxytryptamine release stimulant | 0.403 0.045 DBMET00546 | ||
| 0.506 | 0.006 | 0.527 | Non-steroidal antiinflammatory agent | 0.527 0.005 DBMET00546 | DBMET00546 | |
| 0.504 | 0.004 | 0.505 | Protein kinase stimulant | 0.505 0.004 DBMET00546 | DBMET00546 | |
| 0.52 | 0.02 | 0.571 | Immunomodulator | 0.571 0.014 DBMET00546 | DBMET00546 | |
| 0.485 | 0.004 | 0.485 | Insulin sensitizer | 0.485 0.004 DBMET00546 | ||
| 0.475 | 0.004 | 0.495 | Phospholipase A2 inhibitor | 0.495 0.004 DBMET00546 | DBMET00546 | |
| 0.498 | 0.034 | 0.527 | Immunosuppressant | 0.527 0.026 DBMET00546 | DBMET00546 | |
| 0.466 | 0.004 | 0.474 | Tyrosine 3 hydroxylase inhibitor | 0.474 0.004 DBMET00546 | DBMET00546 | |
| 0.471 | 0.01 | 0.471 | Anesthetic general | 0.384 0.018 DBMET00546 | ||
| 0.494 | 0.034 | 0.494 | 5 Hydroxytryptamine release inhibitor | 0.442 0.055 DBMET00546 | ||
| 0.48 | 0.022 | 0.526 | Antioxidant | 0.526 0.017 DBMET00546 | DBMET00546 | |
| 0.486 | 0.031 | 0.495 | Immunostimulant | 0.495 0.03 DBMET00546 | DBMET00546 | |
| 0.433 | 0.005 | 0.433 | Interleukin 4 antagonist | 0.368 0.005 DBMET00546 | ||
| 0.431 | 0.009 | 0.547 | Phospholipase C inhibitor | 0.547 0.005 DBMET00546 | DBMET00546 | |
| 0.404 | 0.003 | 0.426 | Transcription factor NF kappa B stimulant | 0.426 0.002 DBMET00546 | DBMET00546 | |
| 0.394 | 0.01 | 0.452 | Lipid peroxidase inhibitor | 0.452 0.007 DBMET00546 | DBMET00546 | |
| 0.367 | 0.007 | 0.421 | Gastrin inhibitor | 0.421 0.004 DBMET00546 | DBMET00546 | |
| 0.374 | 0.016 | 0.392 | Hepatoprotectant | 0.392 0.014 DBMET00546 | DBMET00546 | |
| 0.377 | 0.021 | 0.377 | RNA-directed DNA polymerase inhibitor | 0.319 0.028 DBMET00546 | ||
| 0.36 | 0.005 | 0.538 | Succinate dehydrogenase inhibitor | 0.538 0.003 DBMET00546 | DBMET00546 | |
| 0.362 | 0.013 | 0.362 | Monophenol monooxygenase inhibitor | 0.36 0.013 DBMET00546 | ||
| 0.355 | 0.007 | 0.368 | 5-Lipoxygenase inhibitor | 0.368 0.006 DBMET00546 | DBMET00546 | |
| 0.371 | 0.024 | 0.437 | Interleukin agonist | 0.437 0.014 DBMET00546 | DBMET00546 | |
| 0.35 | 0.004 | 0.35 | Vanilloid 1 agonist | 0.342 0.004 DBMET00546 | ||
| 0.364 | 0.027 | 0.407 | DNA synthesis inhibitor | 0.407 0.021 DBMET00546 | DBMET00546 | |
| 0.332 | 0.004 | 0.332 | Toll-Like receptor 2 antagonist | 0.318 0.004 DBMET00546 | ||
| 0.374 | 0.047 | 0.374 | 12-Lipoxygenase inhibitor | 0.357 0.054 DBMET00546 | ||
| 0.348 | 0.032 | 0.383 | Nitric oxide antagonist | 0.383 0.028 DBMET00546 | DBMET00546 | |
| 0.319 | 0.004 | 0.399 | Peroxisome proliferator-activated receptor gamma agonist | 0.399 0.004 DBMET00546 | DBMET00546 | |
| 0.315 | 0.002 | 0.323 | Lysophosphatidic acid 2 receptor antagonist | 0.323 0.002 DBMET00546 | DBMET00546 | |
| 0.361 | 0.05 | 0.361 | Vasodilator, coronary | 0.291 0.095 DBMET00546 | ||
| 0.354 | 0.044 | 0.501 | Interleukin 2 agonist | 0.501 0.008 DBMET00546 | DBMET00546 | |
| 0.33 | 0.024 | 0.33 | P-glycoprotein inhibitor | 0.251 0.041 DBMET00546 | ||
| 0.339 | 0.036 | 0.339 | Transcription factor STAT3 inhibitor | 0.312 0.048 DBMET00546 | ||
| 0.307 | 0.005 | 0.373 | Catenin beta inhibitor | 0.373 0.004 DBMET00546 | DBMET00546 | |
| 0.303 | 0.007 | 0.431 | Adenylate kinase inhibitor | 0.431 0.003 DBMET00546 | DBMET00546 | |
| 0.382 | 0.085 | 0.448 | Antibacterial | 0.448 0.058 DBMET00546 | DBMET00546 | |
| 0.31 | 0.013 | 0.31 | Antipruritic | 0.308 0.013 DBMET00546 | ||
| 0.351 | 0.055 | 0.482 | Aldehyde oxidase inhibitor | 0.482 0.035 DBMET00546 | DBMET00546 | |
| 0.309 | 0.016 | 0.351 | Bone formation stimulant | 0.351 0.013 DBMET00546 | DBMET00546 | |
| 0.305 | 0.012 | 0.305 | Alkylator | 0.297 0.013 DBMET00546 | ||
| 0.328 | 0.042 | 0.328 | Transcription factor STAT inhibitor | 0.31 0.05 DBMET00546 | ||
| 0.282 | 0.005 | 0.282 | Calcium antagonist | 0.158 0.02 DBMET00546 | ||
| 0.279 | 0.003 | 0.279 | Arachidonic acid antagonist | 0.276 0.003 DBMET00546 | ||
| 0.288 | 0.017 | 0.539 | Alpha-N-acetylglucosaminidase inhibitor | 0.539 0.005 DBMET00546 | DBMET00546 | |
| 0.297 | 0.027 | 0.342 | DNA methyltransferase I inhibitor | 0.342 0.015 DBMET00546 | DBMET00546 | |
| 0.311 | 0.049 | 0.331 | Free radical scavenger | 0.331 0.043 DBMET00546 | DBMET00546 | |
| 0.265 | 0.008 | 0.335 | Catalase inhibitor | 0.335 0.005 DBMET00546 | DBMET00546 | |
| 0.299 | 0.045 | 0.471 | 5 Hydroxytryptamine uptake stimulant | 0.471 0.005 DBMET00546 | DBMET00546 | |
| 0.254 | 0.005 | 0.254 | Photosensitizer | 0.24 0.007 DBMET00546 | ||
| 0.271 | 0.026 | 0.36 | Protein-tyrosine phosphatase inhibitor | 0.36 0.011 DBMET00546 | DBMET00546 | |
| 0.251 | 0.008 | 0.251 | Microtubule formation inhibitor | 0.24 0.011 DBMET00546 | ||
| 0.247 | 0.005 | 0.25 | Thioredoxin inhibitor | 0.25 0.005 DBMET00546 | DBMET00546 | |
| 0.335 | 0.095 | 0.542 | Antiobesity | 0.542 0.029 DBMET00546 | DBMET00546 | |
| 0.243 | 0.004 | 0.243 | Ornithine decarboxylase inhibitor | 0.191 0.005 DBMET00546 | ||
| 0.243 | 0.004 | 0.243 | Oleamide hydrolase inhibitor | 0.159 0.005 DBMET00546 | ||
| 0.243 | 0.004 | 0.26 | Adenylate cyclase stimulant | 0.26 0.004 DBMET00546 | DBMET00546 | |
| 0.239 | 0.003 | 0.271 | Vanilloid 2 antagonist | 0.271 0.002 DBMET00546 | DBMET00546 | |
| 0.236 | 0.003 | 0.245 | Acyl-CoA dehydrogenase inhibitor | 0.245 0.003 DBMET00546 | DBMET00546 | |
| 0.236 | 0.005 | 0.236 | Toll-Like receptor 2 agonist | 0.224 0.006 DBMET00546 | ||
| 0.244 | 0.015 | 0.251 | ATPase inhibitor | 0.251 0.013 DBMET00546 | DBMET00546 | |
| 0.234 | 0.006 | 0.328 | TRPA1 agonist | 0.328 0.004 DBMET00546 | DBMET00546 | |
| 0.231 | 0.004 | 0.231 | Acetyl-CoA transferase inhibitor | 0.209 0.004 DBMET00546 | ||
| 0.244 | 0.018 | 0.286 | DNA polymerase I inhibitor | 0.286 0.012 DBMET00546 | DBMET00546 | |
| 0.232 | 0.008 | 0.373 | Glutamate dehydrogenase inhibitor | 0.373 0.004 DBMET00546 | DBMET00546 | |
| 0.255 | 0.036 | 0.266 | Neurotrophic factor enhancer | 0.266 0.03 DBMET00546 | DBMET00546 | |
| 0.223 | 0.005 | 0.275 | Leukotriene antagonist | 0.275 0.004 DBMET00546 | DBMET00546 | |
| 0.259 | 0.043 | 0.319 | DNA methylase inhibitor | 0.319 0.023 DBMET00546 | DBMET00546 | |
| 0.221 | 0.006 | 0.344 | Prolactin inhibitor | 0.344 0.003 DBMET00546 | DBMET00546 | |
| 0.215 | 0.003 | 0.3 | Prostaglandin agonist | 0.3 0.002 DBMET00546 | DBMET00546 | |
| 0.216 | 0.004 | 0.22 | Peroxisome proliferator-activated receptor alpha agonist | 0.22 0.004 DBMET00546 | DBMET00546 | |
| 0.219 | 0.011 | 0.244 | Potassium channel (Ca-activated) activator | 0.244 0.008 DBMET00546 | DBMET00546 | |
| 0.299 | 0.093 | 0.299 | Calcium channel activator | 0.269 0.125 DBMET00546 | ||
| 0.262 | 0.058 | 0.262 | Cyclic AMP phosphodiesterase inhibitor | 0.174 0.117 DBMET00546 | ||
| 0.227 | 0.025 | 0.431 | Insulin secretagoues | 0.431 0.005 DBMET00546 | DBMET00546 | |
| 0.226 | 0.025 | 0.226 | Anesthetic local | 0.092 0.091 DBMET00546 | ||
| 0.203 | 0.003 | 0.211 | Ca2+-transporting ATPase inhibitor | 0.211 0.003 DBMET00546 | DBMET00546 | |
| 0.209 | 0.01 | 0.209 | Gastric antisecretory | 0.147 0.028 DBMET00546 | ||
| 0.216 | 0.018 | 0.659 | GABA C receptor agonist | 0.659 0.002 DBMET00546 | DBMET00546 | |
| 0.221 | 0.023 | 0.28 | Cell wall synthesis inhibitor | 0.28 0.011 DBMET00546 | DBMET00546 | |
| 0.221 | 0.023 | 0.294 | Protein-tyrosine phosphatase 1B inhibitor | 0.294 0.011 DBMET00546 | DBMET00546 | |
| 0.255 | 0.06 | 0.397 | Interleukin antagonist | 0.397 0.031 DBMET00546 | DBMET00546 | |
| 0.197 | 0.002 | 0.197 | Lysophosphatidic acid 3 receptor antagonist | 0.197 0.002 DBMET00546 | ||
| 0.213 | 0.019 | 0.213 | Antibacterial (Helicobacter pylori) | 0.159 0.04 DBMET00546 | ||
| 0.285 | 0.093 | 0.413 | Sodium/bile acid cotransporter inhibitor | 0.413 0.014 DBMET00546 | DBMET00546 | |
| 0.199 | 0.007 | 0.258 | CDC25A inhibitor | 0.258 0.004 DBMET00546 | DBMET00546 | |
| 0.227 | 0.035 | 0.255 | Diuretic | 0.255 0.03 DBMET00546 | DBMET00546 | |
| 0.203 | 0.013 | 0.222 | Mucolytic | 0.222 0.009 DBMET00546 | DBMET00546 | |
| 0.212 | 0.023 | 0.212 | GABA C receptor rho-2 antagonist | 0.186 0.038 DBMET00546 | ||
| 0.247 | 0.058 | 0.247 | Anticonvulsant | 0.211 0.075 DBMET00546 | ||
| 0.211 | 0.023 | 0.222 | Neurotrophic factor | 0.222 0.019 DBMET00546 | DBMET00546 | |
| 0.191 | 0.004 | 0.341 | Prostaglandin F2 alpha antagonist | 0.341 0.003 DBMET00546 | DBMET00546 | |
| 0.245 | 0.06 | 0.253 | Psychostimulant | 0.253 0.057 DBMET00546 | DBMET00546 | |
| 0.204 | 0.02 | 0.232 | Expectorant | 0.232 0.015 DBMET00546 | DBMET00546 | |
| 0.219 | 0.035 | 0.296 | Interferon gamma antagonist | 0.296 0.02 DBMET00546 | DBMET00546 | |
| 0.206 | 0.023 | 0.371 | Cell adhesion inhibitor | 0.371 0.006 DBMET00546 | DBMET00546 | |
| 0.184 | 0.004 | 0.213 | Leukotriene B4 antagonist | 0.213 0.003 DBMET00546 | DBMET00546 | |
| 0.252 | 0.073 | 0.368 | Superoxide dismutase inhibitor | 0.368 0.033 DBMET00546 | DBMET00546 | |
| 0.213 | 0.036 | 0.299 | Melanin inhibitor | 0.299 0.022 DBMET00546 | DBMET00546 | |
| 0.187 | 0.012 | 0.187 | Sphingomyelinase inhibitor | 0.17 0.017 DBMET00546 | ||
| 0.18 | 0.01 | 0.18 | Toll-Like receptor 4 antagonist | 0.179 0.01 DBMET00546 | ||
| 0.178 | 0.008 | 0.195 | Anabolic | 0.195 0.005 DBMET00546 | DBMET00546 | |
| 0.181 | 0.013 | 0.327 | Phosphofructokinase-1 inhibitor | 0.327 0.004 DBMET00546 | DBMET00546 | |
| 0.176 | 0.008 | 0.352 | Alcohol oxidase inhibitor | 0.352 0.004 DBMET00546 | DBMET00546 | |
| 0.194 | 0.028 | 0.284 | Cholesterol synthesis inhibitor | 0.284 0.013 DBMET00546 | DBMET00546 | |
| 0.167 | 0.007 | 0.345 | Glycine transporter 2 inhibitor | 0.345 0.003 DBMET00546 | DBMET00546 | |
| 0.185 | 0.025 | 0.185 | Cyclooxygenase 3 inhibitor | 0.177 0.029 DBMET00546 | ||
| 0.176 | 0.016 | 0.176 | Sphingosine 1-phosphate receptor 4 antagonist | 0.176 0.016 DBMET00546 | ||
| 0.185 | 0.027 | 0.194 | Farnesoid X receptor antagonist | 0.194 0.024 DBMET00546 | DBMET00546 | |
| 0.162 | 0.004 | 0.207 | Thromboxane synthase inhibitor | 0.207 0.003 DBMET00546 | DBMET00546 | |
| 0.202 | 0.044 | 0.248 | Amylase inhibitor | 0.248 0.028 DBMET00546 | DBMET00546 | |
| 0.173 | 0.016 | 0.21 | Caspase 3 inhibitor | 0.21 0.008 DBMET00546 | DBMET00546 | |
| 0.165 | 0.01 | 0.165 | Acetylcholine release stimulant | 0.098 0.093 DBMET00546 | ||
| 0.174 | 0.02 | 0.224 | GABA C receptor antagonist | 0.224 0.009 DBMET00546 | DBMET00546 | |
| 0.177 | 0.026 | 0.206 | Sphingosine 1-phosphate receptor 5 antagonist | 0.206 0.009 DBMET00546 | DBMET00546 | |
| 0.168 | 0.022 | 0.203 | Sphingosine 1-phosphate receptor 2 antagonist | 0.203 0.007 DBMET00546 | DBMET00546 | |
| 0.162 | 0.017 | 0.195 | GABA C receptor rho-1 antagonist | 0.195 0.009 DBMET00546 | DBMET00546 | |
| 0.152 | 0.009 | 0.231 | Leukotriene synthesis inhibitor | 0.231 0.005 DBMET00546 | DBMET00546 | |
| 0.147 | 0.005 | 0.231 | Thromboxane antagonist | 0.231 0.003 DBMET00546 | DBMET00546 | |
| 0.153 | 0.012 | 0.204 | Antimetabolite | 0.204 0.009 DBMET00546 | DBMET00546 | |
| 0.146 | 0.004 | 0.346 | Aconitate hydratase inhibitor | 0.346 0.002 DBMET00546 | DBMET00546 | |
| 0.149 | 0.01 | 0.149 | Amidase inhibitor | 0.132 0.013 DBMET00546 | ||
| 0.148 | 0.01 | 0.384 | Prostaglandin EP2 antagonist | 0.384 0.004 DBMET00546 | DBMET00546 | |
| 0.23 | 0.093 | 0.23 | DNA damaging | 0.18 0.134 DBMET00546 | ||
| 0.145 | 0.011 | 0.145 | Interferon agonist | 0.139 0.012 DBMET00546 | ||
| 0.147 | 0.013 | 0.149 | Lanosterol 14 alpha demethylase inhibitor | 0.149 0.012 DBMET00546 | DBMET00546 | |
| 0.137 | 0.004 | 0.211 | Thromboxane A2 antagonist | 0.211 0.003 DBMET00546 | DBMET00546 | |
| 0.166 | 0.034 | 0.311 | Cystathionine beta-synthase inhibitor | 0.311 0.009 DBMET00546 | DBMET00546 | |
| 0.135 | 0.004 | 0.135 | Acetyl-CoA transferase 1 inhibitor | 0.111 0.004 DBMET00546 | ||
| 0.163 | 0.033 | 0.213 | Aminopeptidase B inhibitor | 0.213 0.019 DBMET00546 | DBMET00546 | |
| 0.14 | 0.011 | 0.205 | Sphingosine 1-phosphate receptor 4 agonist | 0.205 0.004 DBMET00546 | DBMET00546 | |
| 0.139 | 0.01 | 0.145 | ATPase (Vacuolar H+) inhibitor | 0.145 0.009 DBMET00546 | DBMET00546 | |
| 0.135 | 0.008 | 0.182 | CDC25B inhibitor | 0.182 0.005 DBMET00546 | DBMET00546 | |
| 0.146 | 0.021 | 0.349 | Triose-phosphate isomerase inhibitor | 0.349 0.004 DBMET00546 | DBMET00546 | |
| 0.235 | 0.111 | 0.323 | Insulysin inhibitor | 0.323 0.046 DBMET00546 | DBMET00546 | |
| 0.152 | 0.028 | 0.163 | Carbonic anhydrase III inhibitor | 0.163 0.024 DBMET00546 | DBMET00546 | |
| 0.132 | 0.01 | 0.215 | Glycine receptor agonist | 0.215 0.004 DBMET00546 | DBMET00546 | |
| 0.135 | 0.013 | 0.245 | Potassium channel large-conductance Ca-activated activator | 0.245 0.005 DBMET00546 | DBMET00546 | |
| 0.124 | 0.003 | 0.154 | Leukotriene C antagonist | 0.154 0.002 DBMET00546 | DBMET00546 | |
| 0.155 | 0.036 | 0.455 | Ferrochelatase inhibitor | 0.455 0.003 DBMET00546 | DBMET00546 | |
| 0.122 | 0.004 | 0.122 | Exportin-1 inhibitor | 0.088 0.016 DBMET00546 | ||
| 0.147 | 0.03 | 0.23 | AMP-activated protein kinase stimulant | 0.23 0.008 DBMET00546 | DBMET00546 | |
| 0.147 | 0.03 | 0.147 | UDP-glucose 4-epimerase inhibitor | 0.137 0.034 DBMET00546 | ||
| 0.128 | 0.012 | 0.128 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 DBMET00546 | ||
| 0.163 | 0.047 | 0.163 | Toll-Like receptor antagonist | |||
| 0.15 | 0.036 | 0.15 | GABA receptor agonist | 0.134 0.045 DBMET00546 | ||
| 0.181 | 0.067 | 0.404 | Growth hormone agonist | 0.404 0.015 DBMET00546 | DBMET00546 | |
| 0.139 | 0.025 | 0.139 | Topoisomerase II alpha inhibitor | 0.12 0.03 DBMET00546 | ||
| 0.18 | 0.067 | 0.18 | Tumour necrosis factor antagonist | |||
| 0.19 | 0.081 | 0.24 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.24 0.047 DBMET00546 | DBMET00546 | |
| 0.116 | 0.006 | 0.155 | Glutamate (mGluR6) antagonist | 0.155 0.004 DBMET00546 | DBMET00546 | |
| 0.113 | 0.004 | 0.144 | Retinoid X receptor agonist | 0.144 0.003 DBMET00546 | DBMET00546 | |
| 0.253 | 0.145 | 0.415 | Toll-Like receptor agonist | 0.415 0.054 DBMET00546 | DBMET00546 | |
| 0.126 | 0.018 | 0.126 | Glutamate release inhibitor | 0.113 0.028 DBMET00546 | ||
| 0.11 | 0.004 | 0.19 | Prostaglandin E2 agonist | 0.19 0.003 DBMET00546 | DBMET00546 | |
| 0.108 | 0.001 | 0.108 | Lysophosphatidic acid receptor 3 agonist | 0.078 0.002 DBMET00546 | ||
| 0.118 | 0.012 | 0.118 | Elastase 1 inhibitor | 0.099 0.021 DBMET00546 | ||
| 0.114 | 0.008 | 0.114 | Interferon inducer | 0.101 0.012 DBMET00546 | ||
| 0.11 | 0.005 | 0.11 | Nitric oxide donor | 0.089 0.015 DBMET00546 | ||
| 0.124 | 0.02 | 0.204 | Keratolytic | 0.204 0.008 DBMET00546 | DBMET00546 | |
| 0.12 | 0.016 | 0.267 | Carbamoyl phosphate synthetase inhibitor | 0.267 0.005 DBMET00546 | DBMET00546 | |
| 0.105 | 0.002 | 0.105 | Lysophosphatidic acid receptor 1 agonist | 0.099 0.002 DBMET00546 | ||
| 0.114 | 0.011 | 0.114 | Protease 3C (Human rhinovirus) inhibitor | 0.066 0.042 DBMET00546 | ||
| 0.16 | 0.057 | 0.181 | Hemostatic | 0.181 0.042 DBMET00546 | DBMET00546 | |
| 0.113 | 0.009 | 0.148 | Vanilloid 4 agonist | 0.148 0.003 DBMET00546 | DBMET00546 | |
| 0.111 | 0.008 | 0.114 | Fatty acid synthase inhibitor | 0.114 0.008 DBMET00546 | DBMET00546 | |
| 0.117 | 0.015 | 0.139 | Cannabinoid CB1 receptor agonist | 0.139 0.011 DBMET00546 | DBMET00546 | |
| 0.124 | 0.022 | 0.23 | Cell adhesion molecule inhibitor | 0.23 0.007 DBMET00546 | DBMET00546 | |
| 0.162 | 0.061 | 0.174 | Cyclooxygenase inhibitor | 0.174 0.054 DBMET00546 | DBMET00546 | |
| 0.122 | 0.021 | 0.127 | Glutathione S-transferase inhibitor | 0.127 0.019 DBMET00546 | DBMET00546 | |
| 0.175 | 0.076 | 0.292 | Lipocortins synthesis antagonist | 0.292 0.023 DBMET00546 | DBMET00546 | |
| 0.103 | 0.005 | 0.172 | Glucose-6-phosphate isomerase inhibitor | 0.172 0.002 DBMET00546 | DBMET00546 | |
| 0.111 | 0.014 | 0.153 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.153 0.007 DBMET00546 | DBMET00546 | |
| 0.165 | 0.069 | 0.19 | Interleukin 6 antagonist | 0.19 0.047 DBMET00546 | DBMET00546 | |
| 0.123 | 0.028 | 0.123 | Carbonic anhydrase VI inhibitor | 0.106 0.036 DBMET00546 | ||
| 0.122 | 0.029 | 0.122 | Carbonic anhydrase XIII inhibitor | 0.093 0.041 DBMET00546 | ||
| 0.143 | 0.05 | 0.143 | Proteasome inhibitor | 0.117 0.068 DBMET00546 | ||
| 0.105 | 0.013 | 0.138 | Peroxisome proliferator-activated receptor gamma antagonist | 0.138 0.007 DBMET00546 | DBMET00546 | |
| 0.129 | 0.037 | 0.148 | Electron transport complex I inhibitor | 0.148 0.022 DBMET00546 | DBMET00546 | |
| 0.094 | 0.003 | 0.129 | Leukotriene C4 antagonist | 0.129 0.002 DBMET00546 | DBMET00546 | |
| 0.163 | 0.074 | 0.203 | Neurotensin receptor agonist | 0.203 0.033 DBMET00546 | DBMET00546 | |
| 0.103 | 0.014 | 0.103 | Cannabinoid CB2 receptor antagonist | 0.086 0.018 DBMET00546 | ||
| 0.094 | 0.005 | 0.165 | Retinoid X alpha receptor agonist | 0.165 0.003 DBMET00546 | DBMET00546 | |
| 0.112 | 0.024 | 0.317 | Glutamate decarboxylase inhibitor | 0.317 0.003 DBMET00546 | DBMET00546 | |
| 0.106 | 0.018 | 0.108 | Estrogen-related receptor beta agonist | 0.108 0.017 DBMET00546 | DBMET00546 | |
| 0.108 | 0.021 | 0.108 | Epoxide hydrolase inhibitor | 0.083 0.039 DBMET00546 | ||
| 0.114 | 0.028 | 0.114 | Interleukin 5 antagonist | |||
| 0.089 | 0.003 | 0.198 | Prostaglandin D2 agonist | 0.198 0.002 DBMET00546 | DBMET00546 | |
| 0.109 | 0.024 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.114 0.02 DBMET00546 | DBMET00546 | |
| 0.087 | 0.002 | 0.101 | Prostaglandin F2 alpha agonist | 0.101 0.001 DBMET00546 | DBMET00546 | |
| 0.087 | 0.005 | 0.145 | Membrane dipeptidase inhibitor | 0.145 0.002 DBMET00546 | DBMET00546 | |
| 0.104 | 0.025 | 0.104 | Lipase inhibitor | 0.098 0.029 DBMET00546 | ||
| 0.101 | 0.024 | 0.101 | Calcium channel L-type blocker | |||
| 0.086 | 0.01 | 0.086 | Lipocortins synthesis agonist | 0.079 0.014 DBMET00546 | ||
| 0.082 | 0.006 | 0.092 | Pregnane X receptor antagonist | 0.092 0.004 DBMET00546 | DBMET00546 | |
| 0.094 | 0.018 | 0.131 | Phospholipase D inhibitor | 0.131 0.005 DBMET00546 | DBMET00546 | |
| 0.139 | 0.064 | 0.166 | Cyclooxygenase 1 inhibitor | 0.166 0.049 DBMET00546 | DBMET00546 | |
| 0.154 | 0.079 | 0.28 | Thrombolytic | 0.28 0.027 DBMET00546 | DBMET00546 | |
| 0.079 | 0.005 | 0.128 | Peroxisome proliferator-activated receptor alpha antagonist | 0.128 0.004 DBMET00546 | DBMET00546 | |
| 0.139 | 0.068 | 0.139 | Calcium channel blocker | |||
| 0.078 | 0.008 | 0.118 | Peroxisome proliferator-activated receptor delta agonist | 0.118 0.005 DBMET00546 | DBMET00546 | |
| 0.113 | 0.043 | 0.32 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.32 0.005 DBMET00546 | DBMET00546 | |
| 0.078 | 0.008 | 0.097 | Squalene synthetase inhibitor | 0.097 0.006 DBMET00546 | DBMET00546 | |
| 0.231 | 0.163 | 0.231 | Calpain 2 inhibitor | |||
| 0.072 | 0.003 | 0.102 | Lysophosphatidic acid 1 receptor antagonist | 0.102 0.002 DBMET00546 | DBMET00546 | |
| 0.071 | 0.004 | 0.135 | Prostacyclin agonist | 0.135 0.003 DBMET00546 | DBMET00546 | |
| 0.097 | 0.03 | 0.097 | Cannabinoid receptor antagonist | 0.081 0.039 DBMET00546 | ||
| 0.095 | 0.029 | 0.17 | Selectin antagonist | 0.17 0.015 DBMET00546 | DBMET00546 | |
| 0.12 | 0.055 | 0.12 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.075 DBMET00546 | ||
| 0.099 | 0.033 | 0.155 | Glycine receptor antagonist | 0.155 0.006 DBMET00546 | DBMET00546 | |
| 0.067 | 0.002 | 0.067 | Carbonic anhydrase VIII inhibitor | 0.057 0.002 DBMET00546 | ||
| 0.067 | 0.002 | 0.067 | Carbonic anhydrase X inhibitor | 0.057 0.002 DBMET00546 | ||
| 0.142 | 0.078 | 0.142 | Thiol protease inhibitor | 0.138 0.083 DBMET00546 | ||
| 0.068 | 0.004 | 0.128 | Prostaglandin EP4 agonist | 0.128 0.003 DBMET00546 | DBMET00546 | |
| 0.104 | 0.041 | 0.131 | Bile acid receptor antagonist | 0.131 0.013 DBMET00546 | DBMET00546 | |
| 0.071 | 0.007 | 0.189 | Leukotriene D4 antagonist | 0.189 0.004 DBMET00546 | DBMET00546 | |
| 0.074 | 0.012 | 0.074 | Adenosine deaminase inhibitor | 0.074 0.012 DBMET00546 | ||
| 0.111 | 0.048 | 0.204 | Folate antagonist | 0.204 0.009 DBMET00546 | DBMET00546 | |
| 0.065 | 0.003 | 0.065 | Elastase 2B inhibitor | 0.047 0.005 DBMET00546 | ||
| 0.065 | 0.003 | 0.065 | Elastase 3A inhibitor | 0.047 0.005 DBMET00546 | ||
| 0.065 | 0.003 | 0.065 | Elastase 3B inhibitor | 0.047 0.005 DBMET00546 | ||
| 0.066 | 0.004 | 0.103 | Prostaglandin EP2 agonist | 0.103 0.003 DBMET00546 | DBMET00546 | |
| 0.085 | 0.023 | 0.085 | Cannabinoid CB1 receptor antagonist | 0.078 0.028 DBMET00546 | ||
| 0.075 | 0.014 | 0.075 | Acetyl-CoA transferase 2 inhibitor | 0.073 0.015 DBMET00546 | ||
| 0.085 | 0.024 | 0.085 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 DBMET00546 | ||
| 0.062 | 0.003 | 0.062 | Calcium-independent phospholipase A2 inhibitor | 0.052 0.004 DBMET00546 | ||
| 0.189 | 0.13 | 0.189 | Cardiotonic | |||
| 0.069 | 0.011 | 0.069 | Cholesterol esterase inhibitor | 0.055 0.023 DBMET00546 | ||
| 0.08 | 0.023 | 0.396 | Prostaglandin antagonist | 0.396 0.004 DBMET00546 | DBMET00546 | |
| 0.081 | 0.024 | 0.143 | Ribonucleoside-diphosphate reductase inhibitor | 0.143 0.012 DBMET00546 | DBMET00546 | |
| 0.081 | 0.026 | 0.139 | Ribonucleotide reductase inhibitor | 0.139 0.014 DBMET00546 | DBMET00546 | |
| 0.098 | 0.043 | 0.098 | ErbB-3 antagonist | 0.073 0.071 DBMET00546 | ||
| 0.064 | 0.009 | 0.08 | GABA uptake inhibitor | 0.08 0.005 DBMET00546 | DBMET00546 | |
| 0.092 | 0.038 | 0.102 | Thioredoxin reductase inhibitor | 0.102 0.027 DBMET00546 | DBMET00546 | |
| 0.059 | 0.006 | 0.123 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.123 0.004 DBMET00546 | DBMET00546 | |
| 0.059 | 0.007 | 0.129 | Kainate receptor agonist | 0.129 0.002 DBMET00546 | DBMET00546 | |
| 0.167 | 0.117 | 0.167 | Histone acetyltransferase inhibitor | 0.165 0.119 DBMET00546 | ||
| 0.077 | 0.027 | 0.077 | TRPA1 antagonist | 0.07 0.033 DBMET00546 | ||
| 0.064 | 0.014 | 0.164 | Kainate receptor antagonist | 0.164 0.004 DBMET00546 | DBMET00546 | |
| 0.054 | 0.006 | 0.11 | Leukotriene B4 receptor 1 antagonist | 0.11 0.004 DBMET00546 | DBMET00546 | |
| 0.072 | 0.024 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.075 0.023 DBMET00546 | DBMET00546 | |
| 0.072 | 0.025 | 0.154 | Ornithine carbamoyltransferase inhibitor | 0.154 0.009 DBMET00546 | DBMET00546 | |
| 0.074 | 0.027 | 0.074 | Transcription factor AP-1 inhibitor | |||
| 0.115 | 0.069 | 0.127 | Transcription factor STAT6 inhibitor | 0.127 0.048 DBMET00546 | DBMET00546 | |
| 0.061 | 0.014 | 0.061 | Microtubule stabilization | 0.059 0.016 DBMET00546 | ||
| 0.123 | 0.076 | 0.123 | Cyclooxygenase 2 inhibitor | 0.121 0.079 DBMET00546 | ||
| 0.086 | 0.04 | 0.16 | GABA aminotransferase inhibitor | 0.16 0.006 DBMET00546 | DBMET00546 | |
| 0.242 | 0.197 | 0.242 | DNA directed DNA polymerase inhibitor | |||
| 0.136 | 0.091 | 0.154 | Heat shock protein 70 antagonist | 0.154 0.037 DBMET00546 | DBMET00546 | |
| 0.07 | 0.025 | 0.08 | Sphingosine 1-phosphate receptor 3 antagonist | 0.08 0.017 DBMET00546 | DBMET00546 | |
| 0.062 | 0.017 | 0.062 | Leukocyte elastase inhibitor | 0.041 0.032 DBMET00546 | ||
| 0.133 | 0.089 | 0.392 | Peroxidase inhibitor | 0.392 0.022 DBMET00546 | DBMET00546 | |
| 0.05 | 0.008 | 0.063 | Vanilloid 3 antagonist | 0.063 0.004 DBMET00546 | DBMET00546 | |
| 0.098 | 0.057 | 0.113 | Interleukin 12 antagonist | 0.113 0.036 DBMET00546 | DBMET00546 | |
| 0.061 | 0.02 | 0.061 | Squalene epoxidase inhibitor | 0.058 0.023 DBMET00546 | ||
| 0.053 | 0.012 | 0.306 | Fumarate hydratase inhibitor | 0.306 0.003 DBMET00546 | DBMET00546 | |
| 0.081 | 0.042 | 0.131 | Histidine decarboxylase inhibitor | 0.131 0.023 DBMET00546 | DBMET00546 | |
| 0.068 | 0.029 | 0.068 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.054 | 0.016 | 0.068 | G protein-coupled receptor agonist | 0.068 0.01 DBMET00546 | DBMET00546 | |
| 0.098 | 0.061 | 0.171 | Electrolyte absorption antagonist | 0.171 0.013 DBMET00546 | DBMET00546 | |
| 0.048 | 0.013 | 0.048 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.045 0.015 DBMET00546 | ||
| 0.097 | 0.061 | 0.125 | Interleukin 1 beta converting enzyme inhibitor | 0.125 0.031 DBMET00546 | DBMET00546 | |
| 0.045 | 0.01 | 0.061 | HMG CoA reductase inhibitor | 0.061 0.005 DBMET00546 | DBMET00546 | |
| 0.176 | 0.14 | 0.176 | Calpain inhibitor | |||
| 0.048 | 0.014 | 0.098 | Prostacyclin antagonist | 0.098 0.005 DBMET00546 | DBMET00546 | |
| 0.039 | 0.005 | 0.07 | Leukotriene B4 receptor 2 antagonist | 0.07 0.004 DBMET00546 | DBMET00546 | |
| 0.095 | 0.062 | 0.103 | Phosphodiesterase 6D inhibitor | 0.103 0.047 DBMET00546 | DBMET00546 | |
| 0.065 | 0.031 | 0.065 | Carbonic anhydrase VB inhibitor | 0.057 0.038 DBMET00546 | ||
| 0.08 | 0.047 | 0.44 | Porphobilinogen synthase inhibitor | 0.44 0.004 DBMET00546 | DBMET00546 | |
| 0.131 | 0.098 | 0.131 | Neuropeptide Y1 antagonist | |||
| 0.072 | 0.04 | 0.072 | Cannabinoid receptor agonist | 0.067 0.043 DBMET00546 | ||
| 0.052 | 0.019 | 0.056 | Glutamate (mGluR4) antagonist | 0.056 0.016 DBMET00546 | DBMET00546 | |
| 0.133 | 0.1 | 0.191 | Hexokinase inhibitor | 0.191 0.041 DBMET00546 | DBMET00546 | |
| 0.089 | 0.058 | 0.145 | NADH dehydrogenase inhibitor | 0.145 0.019 DBMET00546 | DBMET00546 | |
| 0.047 | 0.015 | 0.068 | Retinoid X receptor antagonist | 0.068 0.004 DBMET00546 | DBMET00546 | |
| 0.053 | 0.022 | 0.053 | Cytokine production stimulant | |||
| 0.054 | 0.023 | 0.054 | Purinergic P2Y antagonist | 0.049 0.027 DBMET00546 | ||
| 0.114 | 0.084 | 0.169 | Cathepsin H inhibitor | 0.169 0.034 DBMET00546 | DBMET00546 | |
| 0.077 | 0.048 | 0.117 | GABA B receptor agonist | 0.117 0.008 DBMET00546 | DBMET00546 | |
| 0.084 | 0.054 | 0.11 | Antineoplastic antibiotic | 0.11 0.042 DBMET00546 | DBMET00546 | |
| 0.033 | 0.004 | 0.033 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET00546 | ||
| 0.057 | 0.028 | 0.057 | Prolyl endopeptidase inhibitor | 0.051 0.035 DBMET00546 | ||
| 0.094 | 0.066 | 0.175 | Creatine kinase inhibitor | 0.175 0.015 DBMET00546 | DBMET00546 | |
| 0.076 | 0.047 | 0.114 | Cathepsin G inhibitor | 0.114 0.029 DBMET00546 | DBMET00546 | |
| 0.036 | 0.008 | 0.061 | Prostaglandin H2 antagonist | 0.061 0.003 DBMET00546 | DBMET00546 | |
| 0.062 | 0.035 | 0.223 | Argininosuccinate synthase inhibitor | 0.223 0.006 DBMET00546 | DBMET00546 | |
| 0.057 | 0.031 | 0.064 | Autotaxin inhibitor | 0.064 0.026 DBMET00546 | DBMET00546 | |
| 0.03 | 0.003 | 0.061 | Thromboxane A2 agonist | 0.061 0.002 DBMET00546 | DBMET00546 | |
| 0.029 | 0.003 | 0.08 | Thromboxane agonist | 0.08 0.002 DBMET00546 | DBMET00546 | |
| 0.03 | 0.004 | 0.03 | Calcium-dependent phospholipase A2 inhibitor | 0.025 0.004 DBMET00546 | ||
| 0.049 | 0.024 | 0.07 | Geranyltranstransferase inhibitor | 0.07 0.008 DBMET00546 | DBMET00546 | |
| 0.168 | 0.143 | 0.168 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.044 | 0.019 | 0.121 | Kainate receptor 2 antagonist | 0.121 0.004 DBMET00546 | DBMET00546 | |
| 0.05 | 0.026 | 0.05 | Benzodiazepine antagonist | |||
| 0.039 | 0.016 | 0.056 | Retinoid X alpha receptor antagonist | 0.056 0.004 DBMET00546 | DBMET00546 | |
| 0.068 | 0.046 | 0.068 | Acetylcholine M5 receptor agonist | |||
| 0.048 | 0.026 | 0.048 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.027 | 0.005 | 0.158 | G-protein-coupled receptor 120 agonist | 0.158 0.002 DBMET00546 | DBMET00546 | |
| 0.171 | 0.149 | 0.175 | Nitric-oxide synthase stimulant | 0.175 0.14 DBMET00546 | DBMET00546 | |
| 0.049 | 0.027 | 0.049 | Adenylate cyclase 1 inhibitor | |||
| 0.034 | 0.013 | 0.11 | Prostaglandin EP4 antagonist | 0.11 0.004 DBMET00546 | DBMET00546 | |
| 0.058 | 0.038 | 0.058 | Beta 1 adrenoreceptor antagonist | |||
| 0.057 | 0.037 | 0.067 | Maillard reaction inhibitor | 0.067 0.031 DBMET00546 | DBMET00546 | |
| 0.024 | 0.005 | 0.034 | Vitamin D receptor agonist | 0.034 0.003 DBMET00546 | DBMET00546 | |
| 0.023 | 0.004 | 0.023 | Carbonic anhydrase XI inhibitor | 0.019 0.004 DBMET00546 | ||
| 0.025 | 0.006 | 0.025 | Toll-Like receptor 8 agonist | |||
| 0.07 | 0.053 | 0.151 | Aminopeptidase I inhibitor | 0.151 0.012 DBMET00546 | DBMET00546 | |
| 0.025 | 0.008 | 0.043 | Retinoid X beta receptor antagonist | 0.043 0.003 DBMET00546 | DBMET00546 | |
| 0.032 | 0.016 | 0.032 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 DBMET00546 | ||
| 0.049 | 0.034 | 0.049 | Carbonic anhydrase XIV inhibitor | |||
| 0.027 | 0.011 | 0.027 | Elastase 2A inhibitor | |||
| 0.027 | 0.011 | 0.027 | Elastase 2 inhibitor | |||
| 0.019 | 0.004 | 0.019 | Calcineurin inhibitor | 0.016 0.004 DBMET00546 | ||
| 0.029 | 0.013 | 0.029 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET00546 | ||
| 0.028 | 0.013 | 0.03 | Purinergic P2Y12 antagonist | 0.03 0.012 DBMET00546 | DBMET00546 | |
| 0.05 | 0.035 | 0.072 | CD45 antagonist | 0.072 0.014 DBMET00546 | DBMET00546 | |
| 0.044 | 0.029 | 0.049 | Glutamate (mGluR group III) antagonist | 0.049 0.022 DBMET00546 | DBMET00546 | |
| 0.039 | 0.024 | 0.083 | Glutamate (mGluR8) agonist | 0.083 0.004 DBMET00546 | DBMET00546 | |
| 0.058 | 0.043 | 0.19 | Biliverdin reductase inhibitor | 0.19 0.006 DBMET00546 | DBMET00546 | |
| 0.058 | 0.043 | 0.084 | Sphingosine kinase inhibitor | 0.084 0.014 DBMET00546 | DBMET00546 | |
| 0.038 | 0.025 | 0.053 | Factor XIIIa inhibitor | 0.053 0.014 DBMET00546 | DBMET00546 | |
| 0.027 | 0.014 | 0.036 | Vanilloid 2 agonist | 0.036 0.005 DBMET00546 | DBMET00546 | |
| 0.032 | 0.019 | 0.129 | Prostaglandin EP3 antagonist | 0.129 0.005 DBMET00546 | DBMET00546 | |
| 0.032 | 0.021 | 0.032 | Methionyl aminopeptidase 1 inhibitor | 0.03 0.026 DBMET00546 | ||
| 0.185 | 0.175 | 0.185 | Thyroid hormone antagonist | |||
| 0.054 | 0.043 | 0.074 | Sphingosine 1-phosphate receptor 1 antagonist | 0.074 0.016 DBMET00546 | DBMET00546 | |
| 0.035 | 0.026 | 0.056 | Nicotinic acid receptor agonist | 0.056 0.012 DBMET00546 | DBMET00546 | |
| 0.035 | 0.026 | 0.054 | Inosine monophosphate dehydrogenase inhibitor | 0.054 0.013 DBMET00546 | DBMET00546 | |
| 0.05 | 0.041 | 0.05 | Cannabinoid CB2 receptor agonist | |||
| 0.097 | 0.088 | 0.097 | Calcium channel (voltage-sensitive) blocker | |||
| 0.052 | 0.044 | 0.052 | Glucosylceramidase inhibitor | 0.052 0.044 DBMET00546 | ||
| 0.15 | 0.142 | 0.174 | Growth factor agonist | 0.174 0.096 DBMET00546 | DBMET00546 | |
| 0.046 | 0.039 | 0.069 | HCV NS3/NS4A protease inhibitor | 0.069 0.015 DBMET00546 | DBMET00546 | |
| 0.041 | 0.033 | 0.042 | GABA B receptor antagonist | 0.042 0.032 DBMET00546 | DBMET00546 | |
| 0.026 | 0.018 | 0.03 | Thyroid hormone agonist | 0.03 0.013 DBMET00546 | DBMET00546 | |
| 0.05 | 0.043 | 0.074 | Alpha-mannosidase inhibitor | 0.074 0.014 DBMET00546 | DBMET00546 | |
| 0.086 | 0.079 | 0.098 | Xanthine oxidase inhibitor | 0.098 0.062 DBMET00546 | DBMET00546 | |
| 0.079 | 0.072 | 0.091 | mTOR complex 2 inhibitor | 0.091 0.046 DBMET00546 | DBMET00546 | |
| 0.04 | 0.033 | 0.048 | Angiotensin AT1 receptor antagonist | 0.048 0.021 DBMET00546 | DBMET00546 | |
| 0.18 | 0.174 | 0.18 | Thyroid hormone beta antagonist | |||
| 0.06 | 0.055 | 0.06 | Beta adrenoreceptor antagonist | |||
| 0.021 | 0.016 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 DBMET00546 | DBMET00546 | |
| 0.057 | 0.054 | 0.091 | Caspase 9 inhibitor | 0.091 0.017 DBMET00546 | DBMET00546 | |
| 0.017 | 0.015 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.023 0.005 DBMET00546 | DBMET00546 | |
| 0.081 | 0.078 | 0.168 | Alcohol dehydrogenase inhibitor | 0.168 0.016 DBMET00546 | DBMET00546 | |
| 0.03 | 0.027 | 0.04 | Calcitonin receptor agonist | 0.04 0.02 DBMET00546 | DBMET00546 | |
| 0.032 | 0.03 | 0.07 | Arginase inhibitor | 0.07 0.008 DBMET00546 | DBMET00546 | |
| 0.027 | 0.026 | 0.027 | Acetylcholine M4 receptor agonist | |||
| 0.014 | 0.013 | 0.014 | Purinergic P2Y1 agonist | |||
| 0.01 | 0.01 | 0.014 | Immunosuppressant Cyclosporine-like | 0.014 0.006 DBMET00546 | DBMET00546 | |
| 0.059 | 0.059 | 0.142 | Phenylalanine 4-hydroxylase inhibitor | 0.142 0.013 DBMET00546 | DBMET00546 | |
| 0.039 | 0.041 | 0.071 | Mannosidase inhibitor | 0.071 0.011 DBMET00546 | DBMET00546 | |
| 0.03 | 0.033 | 0.036 | Angiotensin II receptor antagonist | 0.036 0.021 DBMET00546 | DBMET00546 | |
| 0.022 | 0.025 | 0.034 | Uridine phosphorylase inhibitor | 0.034 0.015 DBMET00546 | DBMET00546 | |
| 0.047 | 0.051 | 0.054 | Nicotinic alpha3beta2 receptor antagonist | 0.054 0.036 DBMET00546 | DBMET00546 | |
| 0.048 | 0.052 | 0.07 | Sphingosine kinase 2 inhibitor | 0.07 0.021 DBMET00546 | DBMET00546 | |
| 0.172 | 0.177 | 0.191 | Neuropeptide Y2 antagonist | 0.191 0.136 DBMET00546 | DBMET00546 | |
| 0.069 | 0.075 | 0.085 | Sphingosine 1-phosphate receptor antagonist | 0.085 0.036 DBMET00546 | DBMET00546 | |
| 0.057 | 0.064 | 0.066 | Carbonic anhydrase VA inhibitor | 0.066 0.051 DBMET00546 | DBMET00546 | |
| 0.053 | 0.06 | 0.14 | NMDA receptor agonist | 0.14 0.009 DBMET00546 | DBMET00546 | |
| 0.029 | 0.036 | 0.061 | 5-Alpha-reductase inhibitor | 0.061 0.015 DBMET00546 | DBMET00546 | |
| 0.014 | 0.022 | 0.097 | Kainate receptor 1 antagonist | 0.097 0.004 DBMET00546 | DBMET00546 | |
| 0.048 | 0.055 | 0.146 | Sphingosine 1-phosphate receptor 5 agonist | 0.146 0.005 DBMET00546 | DBMET00546 | |
| 0.071 | 0.079 | 0.075 | Antineoplastic alkaloid | 0.075 0.072 DBMET00546 | DBMET00546 | |
| 0.025 | 0.033 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 DBMET00546 | DBMET00546 | |
| 0.014 | 0.021 | 0.019 | Telomerase stimulant | 0.019 0.009 DBMET00546 | DBMET00546 | |
| 0.021 | 0.029 | 0.033 | Glutamate (mGluR1) agonist | 0.033 0.008 DBMET00546 | DBMET00546 | |
| 0.023 | 0.032 | 0.036 | Retinoid X gamma receptor antagonist | 0.036 0.006 DBMET00546 | DBMET00546 | |
| 0.05 | 0.059 | 0.058 | Adenine nucleotide translocase inhibitor | 0.058 0.033 DBMET00546 | DBMET00546 | |
| 0.026 | 0.036 | 0.045 | Leukotriene A4 hydrolase inhibitor | 0.045 0.022 DBMET00546 | DBMET00546 | |
| 0.021 | 0.032 | 0.031 | Nicotinic acid receptor 2 antagonist | 0.031 0.012 DBMET00546 | DBMET00546 | |
| 0.025 | 0.036 | 0.031 | Epoxide hydrolase 1 inhibitor | 0.031 0.02 DBMET00546 | DBMET00546 | |
| 0.025 | 0.037 | 0.084 | ATP citrate lysase inhibitor | 0.084 0.004 DBMET00546 | DBMET00546 | |
| 0.052 | 0.065 | 0.058 | Carbonic anhydrase V inhibitor | 0.058 0.056 DBMET00546 | DBMET00546 | |
| 0.027 | 0.04 | 0.049 | Glutamate (mGluR3) agonist | 0.049 0.005 DBMET00546 | DBMET00546 | |
| 0.014 | 0.028 | 0.122 | Prostaglandin D2 antagonist | 0.122 0.004 DBMET00546 | DBMET00546 | |
| 0.075 | 0.089 | 0.101 | Hematopoietic | 0.101 0.035 DBMET00546 | DBMET00546 | |
| 0.078 | 0.092 | 0.086 | Topoisomerase I inhibitor | 0.086 0.083 DBMET00546 | DBMET00546 | |
| 0.046 | 0.06 | 0.055 | Angiotensin-converting enzyme inhibitor | 0.055 0.037 DBMET00546 | DBMET00546 | |
| 0.023 | 0.038 | 0.028 | Purinergic P2Y15 antagonist | 0.028 0.021 DBMET00546 | DBMET00546 | |
| 0.015 | 0.03 | 0.022 | Caspase 8 inhibitor | 0.022 0.01 DBMET00546 | DBMET00546 | |
| 0.027 | 0.042 | 0.042 | Histone deacetylase 7 inhibitor | 0.042 0.022 DBMET00546 | DBMET00546 | |
| 0.027 | 0.042 | 0.045 | Farnesoid X receptor agonist | 0.045 0.018 DBMET00546 | DBMET00546 | |
| 0.035 | 0.051 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.051 0.014 DBMET00546 | DBMET00546 | |
| 0.08 | 0.096 | 0.094 | Nitric-oxide synthase inhibitor | 0.094 0.07 DBMET00546 | DBMET00546 | |
| 0.018 | 0.035 | 0.054 | Lysine carboxypeptidase inhibitor | 0.054 0.007 DBMET00546 | DBMET00546 | |
| 0.06 | 0.077 | 0.081 | MDM2 inhibitor | 0.081 0.018 DBMET00546 | DBMET00546 | |
| 0.007 | 0.024 | 0.024 | Glutamate (mGluR6) agonist | 0.024 0.004 DBMET00546 | DBMET00546 | |
| 0.029 | 0.047 | 0.04 | Dihydropteroate synthase inhibitor | 0.04 0.026 DBMET00546 | DBMET00546 | |
| 0.032 | 0.049 | 0.063 | Sphingosine 1-phosphate receptor 1 agonist | 0.063 0.011 DBMET00546 | DBMET00546 | |
| 0.033 | 0.052 | 0.049 | Sphingosine kinase 1 inhibitor | 0.049 0.017 DBMET00546 | DBMET00546 | |
| 0.026 | 0.048 | 0.038 | Carboxypeptidase B inhibitor | 0.038 0.014 DBMET00546 | DBMET00546 | |
| 0.02 | 0.043 | 0.029 | Histone deacetylase class IV inhibitor | 0.029 0.024 DBMET00546 | DBMET00546 | |
| 0.02 | 0.043 | 0.029 | Histone deacetylase 11 inhibitor | 0.029 0.024 DBMET00546 | DBMET00546 | |
| 0.009 | 0.032 | 0.075 | Free fatty acid receptor 1 agonist | 0.075 0.004 DBMET00546 | DBMET00546 | |
| 0.03 | 0.055 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.03 DBMET00546 | DBMET00546 | |
| 0.009 | 0.034 | 0.025 | Aminopeptidase A inhibitor | 0.025 0.008 DBMET00546 | DBMET00546 | |
| 0.032 | 0.057 | 0.063 | Sphingosine 1-phosphate receptor agonist | 0.063 0.015 DBMET00546 | DBMET00546 | |
| 0.026 | 0.054 | 0.045 | Cholecystokinin B agonist | 0.045 0.019 DBMET00546 | DBMET00546 | |
| 0.022 | 0.051 | 0.039 | Phosphoglycerate kinase inhibitor | 0.039 0.02 DBMET00546 | DBMET00546 | |
| 0.029 | 0.058 | 0.041 | Glycine transporter inhibitor | 0.041 0.04 DBMET00546 | DBMET00546 | |
| 0.166 | 0.196 | 0.181 | Hypoxia-inducible factor 1 alpha inhibitor | 0.181 0.177 DBMET00546 | DBMET00546 | |
| 0.022 | 0.052 | 0.027 | Hedgehog signaling activator | 0.027 0.019 DBMET00546 | DBMET00546 | |
| 0.013 | 0.046 | 0.041 | Kynurenine 3 monooxygenase inhibitor | 0.041 0.009 DBMET00546 | DBMET00546 | |
| 0.09 | 0.123 | 0.122 | Interleukin 8 antagonist | 0.122 0.059 DBMET00546 | DBMET00546 | |
| 0.037 | 0.071 | 0.048 | Bombesin 2 receptor antagonist | 0.048 0.035 DBMET00546 | DBMET00546 | |
| 0.083 | 0.118 | 0.139 | DOPA decarboxylase inhibitor | 0.139 0.028 DBMET00546 | DBMET00546 | |
| 0.007 | 0.043 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 DBMET00546 | DBMET00546 | |
| 0.012 | 0.05 | 0.037 | Retinoid X gamma receptor agonist | 0.037 0.008 DBMET00546 | DBMET00546 | |
| 0.027 | 0.065 | 0.049 | Guanylate cyclase inhibitor | 0.049 0.022 DBMET00546 | DBMET00546 | |
| 0.013 | 0.052 | 0.018 | Retinoic acid beta receptor agonist | 0.018 0.017 DBMET00546 | DBMET00546 | |
| 0.016 | 0.055 | 0.022 | ICAM 1 antagonist | 0.022 0.017 DBMET00546 | DBMET00546 | |
| 0.184 | 0.224 | 0.365 | Toll-Like receptor 7 agonist | 0.365 0.075 DBMET00546 | DBMET00546 | |
| 0.017 | 0.059 | 0.035 | Peptide deformylase inhibitor | 0.035 0.017 DBMET00546 | DBMET00546 | |
| 0.025 | 0.067 | 0.043 | Dopamine D5 agonist | 0.043 0.024 DBMET00546 | DBMET00546 | |
| 0.011 | 0.053 | 0.024 | 5-Alpha-reductase 2 inhibitor | 0.024 0.011 DBMET00546 | DBMET00546 | |
| 0.011 | 0.053 | 0.03 | Retinoid X beta receptor agonist | 0.03 0.008 DBMET00546 | DBMET00546 | |
| 0.004 | 0.047 | 0.027 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.027 0.005 DBMET00546 | DBMET00546 | |
| 0.014 | 0.057 | 0.024 | Urotensin II agonist | 0.024 0.022 DBMET00546 | DBMET00546 | |
| 0.039 | 0.082 | 0.06 | Heparanase inhibitor | 0.06 0.023 DBMET00546 | DBMET00546 | |
| 0.003 | 0.047 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.005 DBMET00546 | DBMET00546 | |
| 0.007 | 0.054 | 0.018 | 5-Alpha-reductase 1 inhibitor | 0.018 0.012 DBMET00546 | DBMET00546 | |
| 0.025 | 0.074 | 0.038 | Retinoic acid alpha receptor agonist | 0.038 0.029 DBMET00546 | DBMET00546 | |
| 0.011 | 0.06 | 0.036 | Glutamate (mGluR1a) agonist | 0.036 0.007 DBMET00546 | DBMET00546 | |
| 0.022 | 0.071 | 0.04 | Oxytocin agonist | 0.04 0.032 DBMET00546 | DBMET00546 | |
| 0.072 | 0.122 | 0.11 | Adenylate cyclase inhibitor | 0.11 0.076 DBMET00546 | DBMET00546 | |
| 0.029 | 0.08 | 0.062 | AICAR transformylase inhibitor | 0.062 0.013 DBMET00546 | DBMET00546 | |
| 0.035 | 0.087 | 0.08 | NMDA receptor glycine site agonist | 0.08 0.028 DBMET00546 | DBMET00546 | |
| 0.027 | 0.08 | 0.037 | Thymidine kinase inhibitor | 0.037 0.035 DBMET00546 | DBMET00546 | |
| 0.017 | 0.07 | 0.045 | Free fatty acid receptor 1 antagonist | 0.045 0.012 DBMET00546 | DBMET00546 | |
| 0.014 | 0.069 | 0.021 | Retinoic acid gamma receptor agonist | 0.021 0.019 DBMET00546 | DBMET00546 | |
| 0.005 | 0.064 | 0.03 | Prostaglandin EP1 antagonist | 0.03 0.01 DBMET00546 | DBMET00546 | |
| 0.067 | 0.128 | 0.089 | ABCA1 expression enhancer | 0.089 0.068 DBMET00546 | DBMET00546 | |
| 0.039 | 0.099 | 0.053 | Dihydroorotate oxidase inhibitor | 0.053 0.043 DBMET00546 | DBMET00546 | |
| 0.016 | 0.077 | 0.064 | GP IIb/IIIa receptor antagonist | 0.064 0.026 DBMET00546 | DBMET00546 | |
| 0.015 | 0.076 | 0.028 | LFA antagonist | 0.028 0.019 DBMET00546 | DBMET00546 | |
| 0.032 | 0.097 | 0.089 | Glucagon-like peptide 1 agonist | 0.089 0.029 DBMET00546 | DBMET00546 | |
| 0.03 | 0.095 | 0.048 | Diacylglycerol O-acyltransferase inhibitor | 0.048 0.039 DBMET00546 | DBMET00546 | |
| 0.044 | 0.11 | 0.066 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.066 0.065 DBMET00546 | DBMET00546 | |
| 0.039 | 0.105 | 0.092 | Purinergic P2X1 antagonist | 0.092 0.019 DBMET00546 | DBMET00546 | |
| 0.021 | 0.087 | 0.054 | Glutamate (mGluR3) antagonist | 0.054 0.01 DBMET00546 | DBMET00546 | |
| 0.045 | 0.113 | 0.064 | Ryanodine receptor antagonist | 0.064 0.027 DBMET00546 | DBMET00546 | |
| 0.046 | 0.117 | 0.084 | Glutamate (mGluR7) antagonist | 0.084 0.023 DBMET00546 | DBMET00546 | |
| 0.106 | 0.18 | 0.139 | Pregnane X receptor agonist | 0.139 0.076 DBMET00546 | DBMET00546 | |
| 0.033 | 0.112 | 0.075 | Carbonic anhydrase stimulant | 0.075 0.028 DBMET00546 | DBMET00546 | |
| 0.028 | 0.107 | 0.044 | VCAM-1 antagonist | 0.044 0.015 DBMET00546 | DBMET00546 | |
| 0.028 | 0.108 | 0.044 | VCAM antagonist | 0.044 0.015 DBMET00546 | DBMET00546 | |
| 0.012 | 0.094 | 0.035 | Caspase 2 inhibitor | 0.035 0.019 DBMET00546 | DBMET00546 | |
| 0.077 | 0.159 | 0.096 | Factor V inhibitor | 0.096 0.078 DBMET00546 | DBMET00546 | |
| 0.027 | 0.112 | 0.05 | Integrin alpha1beta1 antagonist | 0.05 0.008 DBMET00546 | DBMET00546 | |
| 0.112 | 0.198 | 0.169 | Antiamyloidogenic | 0.169 0.124 DBMET00546 | DBMET00546 | |
| 0.022 | 0.11 | 0.086 | Prostaglandin E2 antagonist | 0.086 0.018 DBMET00546 | DBMET00546 | |
| 0.023 | 0.116 | 0.053 | Glutamate (mGluR8) antagonist | 0.053 0.007 DBMET00546 | DBMET00546 | |
| 0.097 | 0.192 | 0.157 | Dual specificity phosphatase inhibitor | 0.157 0.086 DBMET00546 | DBMET00546 | |
| 0.228 | 0.325 | 0.289 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.289 0.228 DBMET00546 | DBMET00546 | |
| 0.002 | 0.1 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DBMET00546 | DBMET00546 | |
| 0.017 | 0.119 | 0.038 | Peroxisome proliferator-activated receptor delta antagonist | 0.038 0.017 DBMET00546 | DBMET00546 | |
| 0.081 | 0.183 | 0.12 | Anticoagulant | 0.12 0.112 DBMET00546 | DBMET00546 | |
| 0.051 | 0.155 | 0.134 | HIV-1 integrase (Overall Integration) inhibitor | 0.134 0.032 DBMET00546 | DBMET00546 | |
| 0.056 | 0.161 | 0.121 | Chelator | 0.121 0.053 DBMET00546 | DBMET00546 | |
| 0.007 | 0.12 | 0.032 | Sphingosine 1-phosphate receptor 3 agonist | 0.032 0.026 DBMET00546 | DBMET00546 | |
| 0.025 | 0.141 | 0.039 | Glucagon-like peptide 1 receptor antagonist | 0.039 0.028 DBMET00546 | DBMET00546 | |
| 0.072 | 0.194 | 0.122 | Histone deacetylase SIRT1 inhibitor | 0.122 0.089 DBMET00546 | DBMET00546 | |
| 0.064 | 0.189 | 0.091 | Glutamate (mGluR7) agonist | 0.091 0.08 DBMET00546 | DBMET00546 | |
| 0.017 | 0.143 | 0.058 | Thymidylate synthase inhibitor | 0.058 0.018 DBMET00546 | DBMET00546 | |
| 0.085 | 0.211 | 0.141 | NOS3 expression enhancer | 0.141 0.082 DBMET00546 | DBMET00546 | |
| 0.019 | 0.148 | 0.054 | AMPA 4 receptor antagonist | 0.054 0.013 DBMET00546 | DBMET00546 | |
| 0.005 | 0.136 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.012 DBMET00546 | DBMET00546 | |
| 0.017 | 0.152 | 0.06 | NMDA 2C receptor antagonist | 0.06 0.044 DBMET00546 | DBMET00546 | |
| 0.016 | 0.152 | 0.045 | Aldose reductase inhibitor | 0.045 0.044 DBMET00546 | DBMET00546 | |
| 0.008 | 0.144 | 0.029 | AMPA 3 receptor antagonist | 0.029 0.021 DBMET00546 | DBMET00546 | |
| 0.056 | 0.199 | 0.083 | D-Ala-D-Ala ligase inhibitor | 0.083 0.061 DBMET00546 | DBMET00546 | |
| 0.084 | 0.261 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.102 DBMET00546 | DBMET00546 | |
| 0.006 | 0.185 | 0.026 | Glucagon receptor antagonist | 0.026 0.024 DBMET00546 | DBMET00546 | |
| 0.016 | 0.196 | 0.085 | Plasminogen activator inhibitor antagonist | 0.085 0.014 DBMET00546 | DBMET00546 | |
| 0.007 | 0.187 | 0.035 | Urate transporter 1 inhibitor | 0.035 0.033 DBMET00546 | DBMET00546 | |
| 0.118 | 0.316 | 0.21 | Peptidyltransferase inhibitor | 0.21 0.087 DBMET00546 | DBMET00546 | |
| 0.014 | 0.213 | 0.039 | NMDA receptor subunit 3B antagonist | 0.039 0.036 DBMET00546 | DBMET00546 | |
| 0.01 | 0.251 | 0.043 | Macrophage elastase inhibitor | 0.043 0.03 DBMET00546 | DBMET00546 | |
| 0.034 | 0.38 | 0.11 | Nav1.4 sodium channel blocker | 0.11 0.063 DBMET00546 | DBMET00546 | |
| 0.005 | 0.369 | 0.023 | Integrin alphaVbeta3 antagonist | 0.023 0.014 DBMET00546 | DBMET00546 | |
| 0.005 | 0.374 | 0.043 | Integrin antagonist | 0.043 0.03 DBMET00546 | DBMET00546 | |
| 0.005 | 0.411 | 0.015 | Integrin beta6 antagonist | 0.015 0.009 DBMET00546 | DBMET00546 | |
| 0.015 | 0.735 | 0.05 | DNA helicase inhibitor | 0.05 0.048 DBMET00546 | DBMET00546 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |